SC
CDNA icon

Selz Capital’s CareDx CDNA Stock Holding History

Selz Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.76M Buy
+81,800
New +$1.88M 0.31% 49

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Selz Capital's CDNA Position: Q4 2019 in Review

Selz Capital opened a new position in CareDx (CDNA) in Q4 2019: 81,800 shares worth $1.76M. The stake represents 0.31% of the portfolio and ranks #49 among its holdings.

159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

  • Selz Capital held 81,800 shares of CareDx worth $1.76M as of Q4 2019.
  • CareDx was a new Selz Capital position in Q4 2019.
  • CareDx made up 0.31% of Selz Capital's portfolio in Q4 2019, its #49 holding.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Selz Capital's 13F filing for Q4 2019, filed 16 Jan 2020.